Publications
5539 Results
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:1a(#1)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. results of Intergroup study INT-0116 (SWOG 9008)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:487a(#1906)
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9416
Induction chemoradiation plus surgical resection is feasible and highly effective treatment for pancoast tumors: initial results of SWOG 9416 (Intergroup 0160) trial
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:240a(#931)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)
Phase III randomized trial of bolus 5-FU/leucovorin/levamisole versus 5-FU continuous infusion/levamisole as adjuvant therapy for high risk colon cancer (SWOG 9415/INT-0153)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:85a(#326)
- Year
- 2000
- Research Committee(s)
- Breast
- Study Number(s)
- S9625
Neoadjuvant doxorubicin, cyclophosphamide and G-CSF (AC+G) for locally advanced breast cancer (LABC), a Southwest Oncology Group phase II study
- Journal / Conference
- Journal of Urology 163(4):56Suppl(#242)
- Year
- 2000
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8894 (INT-0105) (EST-2889)
African American ethnic background is an independent and negative predictor of survival in metastatic prostate cancer
- Journal / Conference
- Journal of Urology 163(4)Suppl:154
- Year
- 2000
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8949
Cytoreduction nephrectomy in metastatic renal cancer: the results of Southwest Oncology Group trial 8949
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:328a(#1291)
- Year
- 2000
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9452 (INT-0159) (CALGB 9480)
Results of CALGB 9480, a phase III trial of 3 different doses of suramin for the treatment of hormone refractory prostate cancer (HRPC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 19:384a(#1520)
- Year
- 2000
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9326
Altretamin (Hexalen) consolidation for patients with stage III epithelial ovarian cancer in clinical complete remission: a Southwest Oncology Group trial (S9326)
- Journal / Conference
- Proc of the Society for Clinical Trials :#11
- Year
- 2000
- Research Committee(s)
- Prevention and Epidemiology
- Study Number(s)
- S0000
Design of the selenium and vitamin E chemoprevention trial (SELECT)
- Journal / Conference
- Proc of the Melanoma at the Millennium :79
- Year
- 2000
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9035